J4 ›› 2010, Vol. 48 ›› Issue (05): 871-875.

• 生命科学 • 上一篇    

人突变型CDK2(F80A)稳定细胞系的建立

王佳思, 金英花   

  1. 吉林大学 分子酶学工程教育部重点实验室, 长春 130021
  • 收稿日期:2010-01-22 出版日期:2010-09-26 发布日期:2010-09-21
  • 通讯作者: 金英花 E-mail:yhjin@jlu.edu.cn

Establishment of a HeLa Cell Line Stably ExpressingHuman Mutated CDK2(F80A)

WANG Jiasi, JIN Yinghua   

  1. Key Laboratory for Molecular Enzymology &|Engineering of the Ministry of Education,Jilin University, Changchun 130021, China
  • Received:2010-01-22 Online:2010-09-26 Published:2010-09-21
  • Contact: JIN Yinghua E-mail:yhjin@jlu.edu.cn

摘要:

将CDK2激酶第80位的Phe突变成Ala, 使该激酶特异地利用ATP类似物N6-(2-苯乙基)-ATP(PE-ATP)筛选CDK2激酶的体内特异性底物. 将pCMV-CDK2(F80A)-myc载体转染人宫颈癌细胞(HeLa), 经持续G418选择和克隆化获得6株抗G418细胞系. Immunoblotting分析发现, 挑选的6株细胞系中有4株表达带有myc标签的人突变CDK2蛋白质, 其中2株表达量较高, 可以作为筛选CDK2底物的细胞系.

关键词: 稳定细胞系; CDK2; , 突变; 细胞凋亡

Abstract:

Mutation(F80A)on CDK2 kinase allows the selective use of an ATP analogue N6-(2-phenylethyl)-ATP (PE-ATP), which exhibits high affinity for the altered CDK2. Using modified CDK2 and its ATP analogue enables the detection of novel CDK2 substrates in cells. Modified CDK2 (F80A)myc was cloned into pCMV vector, and transfected into HeLa cells by polyfect transfection reagent. The cells expressing mutant CDK2 were selected by the ability of resistance to G418. The stably transfected cell line was identified by immunoblotting. Four out of the six mutants showed CDK2(F80A)myc expression, and two of them got a higher expression level. The higher CDK2(F80A)myc expressing cell lines can be used for screening CDK2 substrates in cells.

Key words: stable cell line; CDK2; mutation; apoptosis

中图分类号: 

  • Q786